Dr Christy Goldsmith

Action Radiotherapy

Dr Christy Goldsmith undertook a travel fellowship in aspects of SABR in 2009, learning Linac-based technique at the NKI, Amsterdam, and CyberKnife technique at Stanford University hospital, USA. This experience furthered Dr Goldsmith’s interest in SABR technique and she took up a CyberKnife Fellow post at The Harley Street Clinic, London, studying for an MD(Res) thesis on “Optimising dose delivery and tracking accuracy in SABR”. Dr Goldsmith has presented Abstracts on SABR for Oligometastatic disease at ESTRO, ASTRO and the RSS Scientific meeting.

dont miss

Improving patient outcomes with Stereotactic Ablative Body Radiotherapy (SABR)

SABR is a fairly new Radiotherapy treatment approach. High dose radiotherapy is delivered with pin-point accuracy. Patients typically benefit from improved tumour control, and fewer side effects. The treatment duration is also shorter than “standard” radiotherapy meaning patients can get back to normal life much quicker. SABR will be explained to the audience.

EVEN MORE SEMINARS

  • Emlyn Samuel: Speaking at the Oncology Convention

    Emlyn Samuel
    Cancer Research UK

    Brexit: getting the best outcome for research and patients

  • Professor Patricia Price: Speaking at the Oncology Convention

    Professor Patricia Price
    Action Radiotherapy

    Action Radiotherapy -a charity for radiotherapy patients and professionals.

  • Nizar Asadi: Speaking at the Oncology Convention

    Nizar Asadi
    Royal Brompton & Harefield NHS Foundation Trust

    Thoracic surgery in the treatment of lung cancer

  • Profess Liz Ward: Speaking at the Oncology Convention

    Profess Liz Ward
    Centre for Functioning and Health Research, Metro South Hospital and Health Service, and The Univers

    Laryngectomy rehabilitation: Opportunities for improving speech pathology supports via telehealth

  • Dr Tom Newsom-Davis: Speaking at the Oncology Convention

    Dr Tom Newsom-Davis
    Leaders in Oncology Care (Part of HCA healthcare UK)

    Immunotherapy and innovative systemic treatments in Oncology